SUNREST LIFESCIENCE LTD Financial Ratios
SUNREST · Healthcare · Current price ₹36.5
P/E ratio
7.6x
P/B ratio
0.9x
ROE
22.4%
ROCE
28.6%
Debt / Equity
0.85
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 7.6x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.9x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 22.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 28.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.85 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with SUNREST LIFESCIENCE LTD's latest numbers.
SUNREST LIFESCIENCE LTD profitability
SUNREST LIFESCIENCE LTD generates a return on equity of 22.4% and a return on capital employed of 28.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.85 and a P/E of 7.6x, SUNREST LIFESCIENCE LTD is moderately leveraged. Our overall business-quality score for the company is 6.3 / 10.
Understand the ratios
More on SUNREST LIFESCIENCE LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.